<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03106974</url>
  </required_header>
  <id_info>
    <org_study_id>totaltrackeca01</org_study_id>
    <nct_id>NCT03106974</nct_id>
  </id_info>
  <brief_title>A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Obese Patients</brief_title>
  <acronym>Ovesion</acronym>
  <official_title>A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AnestesiaR</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AnestesiaR</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Airway management in obese patients has to consider that mask ventilation (DMV) risk is
      increased and difficult tracheal intubation (DTI) risk may be increased too.

      In obese patients, is essential to prevent early arterial oxygen desaturation related to a
      reduced functional residual capacity (FRC), atelectasis formation during anesthetic induction
      and after tracheal intubation, because oxygenation maintenance is the cornerstone of the
      airway management of the obese patient.

      Endotracheal intubation is usually required to allow unrestricted surgical approach. The
      Macintosh laryngoscope is the standard method. However, sometimes this technique is
      ineffective and poorly tolerated by the obese patient.

      The Totaltrack™ (MedComflow S.A., Barcelona, Spain) is a hybrid device, between a
      supraglottic airway and a videolaryngoscope with an anatomically shaped blade. It allows
      fibreoptic visualization of the larynx for tracheal intubation and was developed to aid both
      ventilation and tracheal intubation, at the time of anticipated and unanticipated difficult
      airway management.

      However, despite its use in clinical practice, there are no comparative studies regarding
      direct laryngoscopy in obese patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2017</start_date>
  <completion_date type="Anticipated">May 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>saturation of blood oxygen at the end of orotracheal intubation</measure>
    <time_frame>Time of Orotracheal intubation (TOTI) (up to 1 hour)</time_frame>
    <description>We will compare the blood oxygen saturation at the end of orotracheal intubation with macintosh and totaltrack.
The end of successful tracheal intubation will be established to obtain a curve of Capnography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total time of successful intubation</measure>
    <time_frame>Time of Orotracheal intubation (TOTI) (up to 1 hour)</time_frame>
    <description>Total time of successful intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of maneuvers</measure>
    <time_frame>Time of Orotracheal intubation (TOTI) (up to 1 hour)</time_frame>
    <description>number of maneuvers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IDS Scale</measure>
    <time_frame>Time of Orotracheal intubation (TOTI) (up to 1 hour)</time_frame>
    <description>IDS Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POGO Score</measure>
    <time_frame>Time of Orotracheal intubation (TOTI) (up to 1 hour)</time_frame>
    <description>POGO Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of attempts of endotracheal intubation</measure>
    <time_frame>Time of Orotracheal intubation (TOTI) (up to 1 hour)</time_frame>
    <description>Number of attempts of endotracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemodynamic response</measure>
    <time_frame>TOTI pre and postintubation (up to 10 minutes)</time_frame>
    <description>hemodynamic response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of satisfaction of the researcher</measure>
    <time_frame>time of postintubation (up to 10 minutes)</time_frame>
    <description>Visual Analogic Scale (0-5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effects encountered during intubation</measure>
    <time_frame>Time of Orotracheal intubation (TOTI) (up to 1 hour)</time_frame>
    <description>adverse effects encountered during intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Time Frame: TOTI and postintubation (up to 24 hours)</time_frame>
    <description>Complications after intubation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1440</enrollment>
  <condition>Endotracheal Intubation</condition>
  <condition>Obesity</condition>
  <condition>Desaturation</condition>
  <condition>Ventilation</condition>
  <arm_group>
    <arm_group_label>Macintosh Laryngoscope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>orotracheal intubation (OTI) with Macintosh Laryngoscope Direct laryngoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Totaltrack VLM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>orotracheal intubation (OTI) with Totaltrack VlM Indirect laryngoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>orotracheal intubation Macintosh Laryngoscope</intervention_name>
    <description>orotracheal intubation (OTI) after induction of anesthesia and complete relaxation</description>
    <arm_group_label>Macintosh Laryngoscope</arm_group_label>
    <other_name>OTI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>orotracheal intubation Totaltrack VLM</intervention_name>
    <description>orotracheal intubation (OTI) after induction of anesthesia and complete relaxation</description>
    <arm_group_label>Totaltrack VLM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 30.

          -  ASA 1-3

          -  Scheduled surgeries that require orotracheal intubation.

          -  General anesthesia with neuromuscular relaxation before intubation.

          -  Patients who sign informed consent.

        Exclusion Criteria:

          -  ASA 4

          -  Difficult airway already known.

          -  Alterations of airway documented, with previous tracheostomy or involve anatomical
             alterations.

          -  General anesthesia that not require orotracheal intubation or neuromuscular
             relaxation.

          -  Symptomatic gastro-esophageal reflux.

          -  Lap-Band carrier.

          -  Allergy medications to use.

          -  Urgent surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Luisa Mariscal Flores, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Getafe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Míriam Sánchez Merchante, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Fundación Alcorcón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sergio D. Bergese, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Faculty - Wexner Medical Center at The Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eugenio D. Martinez Hurtado, M.D.</last_name>
    <email>OvesionTT@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Leonor</name>
      <address>
        <city>Madrid</city>
        <zip>28031</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugenio D. Martinez Hurtado, M.D.</last_name>
      <email>OvesionTT@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Eugenio D. Martinez Hurtado, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Luisa Mariscal Flores, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Míriam Sánchez Merchante, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergio D. Bergese, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2017</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>AnestesiaR</investigator_affiliation>
    <investigator_full_name>Eugenio Martinez Hurtado</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>CITATIONS</doc_type>
      <doc_url>https://goo.gl/px0x0N</doc_url>
      <doc_comment>CITATIONS</doc_comment>
    </study_doc>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>https://goo.gl/wk5OcZ</doc_url>
      <doc_comment>Study Protocol</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>CEIC Aprobation</doc_id>
      <doc_type>CEIC Aprobation</doc_type>
      <doc_url>https://goo.gl/rRujB0</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>https://goo.gl/niXEdA</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://goo.gl/NOzcYq</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

